During the past decade, Parkwood Institute conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 6 clinical trials were completed, i.e. on average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 4 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parkwood Institute" #1 sponsor was "Lawson Health Research Institute" with 15 trials, followed by "University of British Columbia" with 5 trials sponsored, "Mannkind Corporation" with 4 trials sponsored, "Genentech, Inc." with 3 trials sponsored and "Alzheimer's Disease Cooperative Study (ADCS)" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parkwood Institute" #1 collaborator was "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Northern California Institute of Research and Education" with 4 trials as a collaborator, "Parkwood Hospital, London, Ontario" with 4 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator and "Sunnybrook Health Sciences Centre" with 3 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Parkwood Institute" are "Alzheimer's Disease" (13 trials), "Stroke" (6 trials), "Alzheimer Disease" (5 trials), "Brain Diseases" (4 trials) and "Brain Infarction" (4 trials). Many other conditions were trialed in "Parkwood Institute" in a lesser frequency.

Most popular intervention types in "Parkwood Institute" are "Drug" (32 trials), "Other" (12 trials), "Device" (8 trials), "Behavioral" (5 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Donepezil" (2 trials), "Exercise Program" (2 trials), "Placebo Control" (2 trials) and "Technosphere Insulin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Parkwood Institute" are 53 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Parkwood Institute". 3 are not yet recruiting, 12 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Parkwood Institute, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Parkwood Institute, 3 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 17 trials that are defined as “Not Applicable".